Virginia Retirement Systems Et Al Atea Pharmaceuticals, Inc. Transaction History

Virginia Retirement Systems Et Al

  • $10.1 Billion
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Jul 11, 2023
SELL
$3.0 - $4.97 $52,200 - $86,478
-17,400 Reduced 29.19%
42,200 $141,000
Q4 2022

May 17, 2023
BUY
$4.35 - $6.17 $141,375 - $200,525
32,500 Added 119.93%
59,600 $287 Million
Q3 2022

May 16, 2023
BUY
$5.49 - $8.79 $41,175 - $65,925
7,500 Added 38.27%
27,100 $154 Million
Q1 2022

Apr 21, 2022
BUY
$5.5 - $9.19 $107,800 - $180,124
19,600 New
19,600 $142,000

Others Institutions Holding AVIR

# of Institutions
112
Shares Held
52.4M
Call Options Held
900
Put Options Held
126K
View Full List

About Atea Pharmaceuticals, Inc.

AVIR Quotes by TradingView
  • Ticker AVIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,258,600
  • Market Cap $283M
  • Description
  • Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...
More about AVIR
Track This Portfolio

Track Virginia Retirement Systems Et Al Portfolio

Follow Virginia Retirement Systems Et Al and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email